We are convinced that public dialogue is crucial to advance ideas and enrich people’s understanding of the domain in which they operate. This approach is all the more important when dealing with a concept like needs-driven innovation for health. Innovation has many meanings and we would like this pluralism to emerge through individual understandings, experiences and cultural perspectives.
Dr Marie-Paule Kieny, Assistant Director General for Innovation, Information, Evidence and Research of the World Health Organisation gives her assessment of the intergovernmental discussions of the report of the Consultative Expert Working Group on Research and Development Financing and Coordination (CEWG) and expresses her expectations from the national and regional consultations requested by the World Health Assembly.
A presentation by Janis K. Lazdins-Helds:
Business models to address research and development for products for neglected diseases. Implications for developing countries.
Many health actors contribute in their own ways to strengthening innovation for health and improving people’s access to its results. Policy-makers, health professionals, researchers, and other actors at national, regional or international level all influence and shape innovation for health. In which way does your work contribute to innovation for health?